Inclusion Body Myositis News and Research

RSS
Idera begins enrollment in IMO-8400 Phase 2 clinical trial for treatment of dermatomyositis

Idera begins enrollment in IMO-8400 Phase 2 clinical trial for treatment of dermatomyositis

FDA awards research grants to boost product development for patients with rare diseases

FDA awards research grants to boost product development for patients with rare diseases

Former all-American wrestler speaks about his personal battle with chronic muscle disease

Former all-American wrestler speaks about his personal battle with chronic muscle disease

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

New antibody could boost strength, muscle mass in patients with cancer and other diseases

New antibody could boost strength, muscle mass in patients with cancer and other diseases

FDA grants Orphan Drug designation to Milo Biotechnology's AAV1-FS344 inhibitor

FDA grants Orphan Drug designation to Milo Biotechnology's AAV1-FS344 inhibitor

Columbus hospital receives PPMD grant to conduct clinical testing for Duchenne

Columbus hospital receives PPMD grant to conduct clinical testing for Duchenne

Gene delivery strategy to help improve muscle mass in patients with degenerative muscle disorders

Gene delivery strategy to help improve muscle mass in patients with degenerative muscle disorders

Alzheimer's vaccine slows progression of inclusion body myositis

Alzheimer's vaccine slows progression of inclusion body myositis

Gene therapy for muscular dystrophy a step closer

Gene therapy for muscular dystrophy a step closer

Lithium chloride slows development of inclusion body myositis

Lithium chloride slows development of inclusion body myositis

Massive microRNA scan uncovers leads to treating muscle degeneration

Massive microRNA scan uncovers leads to treating muscle degeneration

Myositis featured on Discovery Channel

Myositis featured on Discovery Channel

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease